We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current CVAC market cap is 784.56M. The company's latest EPS is EUR -1.1623 and P/E is -3.05.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | -14.5M | 8.83M | 8.85M | 16.92M | 27.12M |
| Operating Income | -102.85M | -60.66M | -89.13M | -54.51M | -88.25M |
| Net Income | -128.78M | -57.42M | -67.41M | -48.68M | -86.65M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 23M | 73.02M | 744.92M | 105.35M | 61.71M |
| Operating Income | -99.5M | -109.82M | -412.26M | -231.1M | -275.4M |
| Net Income | -99.87M | -129.12M | -411.72M | -249.03M | -260.17M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 860.47M | 973.67M | 899.48M | 842.57M | 788.25M |
| Total Liabilities | 327.22M | 260.27M | 250.43M | 240.3M | 271.31M |
| Total Equity | 533.25M | 713.4M | 649.05M | 602.27M | 516.94M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 130.62M | 1.51B | 1.16B | 860.47M | 788.25M |
| Total Liabilities | 173.42M | 800.01M | 469.77M | 327.22M | 271.31M |
| Total Equity | -42.8M | 711.35M | 688.48M | 533.25M | 516.94M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -286.18M | -99.59M | -163.7M | -224.28M | -267.89M |
| Investing | -93.5M | -13.16M | -27.37M | -40.79M | -55.2M |
| Financing | 63.17M | 234.71M | 233.51M | 232.3M | 230.89M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -86.96M | 522.4M | -733.13M | -286.18M | -267.89M |
| Investing | 28.18M | -45.27M | -127.9M | -93.5M | -55.2M |
| Financing | 67.98M | 819.83M | 344.96M | 63.17M | 230.89M |
| Market Cap | 784.56M |
| Price to Earnings Ratio | -3.05 |
| Price to Sales Ratio | 12.84 |
| Price to Cash Ratio | 1.97 |
| Price to Book Ratio | 1.53 |
| Dividend Yield | - |
| Shares Outstanding | 223.84M |
| Average Volume (1 week) | 556.41k |
| Average Volume (1 Month) | 676.69k |
| 52 Week Change | -60.79% |
| 52 Week High | 12.36 |
| 52 Week Low | 2.215 |
| Spread (Intraday) | 0.01 (0.28%) |
| Company Name | CureVac NV |
| Address |
friedrich-miescher-strasse 15 tubingen 72076 |
| Website | https://www.curevac.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
